Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 520
Selected: 0
NCT IDTitle
NCT00418496Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma
NCT04906382Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
NCT05141682Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
NCT00201773Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
NCT04427566Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise
NCT02053662Biomarker Identification for Bladder Cancer Patients
NCT06635005A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women
NCT00601926Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
NCT02193568Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy
NCT02299518Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT00729118Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT018211052 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer
NCT02596685Effects of Electronic Cigarette Use on the Lungs
NCT02262325Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
NCT05178498Impact of Dietary Inflammatory Potential on Breast Cancer Risk
NCT01129206Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
NCT00754923Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT05412875Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung
NCT05674578Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors
NCT01764789Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
NCT06038526Evaluation of Canakinumab in High-Risk Former-Smokers
NCT00201812Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
NCT06763536Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia
NCT05264532Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations
NCT02831582Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
NCT02760030Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
NCT06260683A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
NCT04120454Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer
NCT05845476Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation
NCT00816335Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
NCT04862650Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT01129193AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
NCT07227038Living Well With Advanced Breast Cancer
NCT00230126OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer
NCT05012176An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors
NCT01129180Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT04140513Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer
NCT00983359Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
NCT02049541Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma
NCT00569309Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
NCT01478477Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
NCT07676877Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
NCT02122081Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
NCT03824327Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
NCT04919369All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
NCT06330805Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
NCT06528769Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
NCT01812005Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
NCT01219777Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
NCT06263153Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy